Autumn Shareholder Reception
We held our Autumn Shareholder Reception at Calla Lily Clinical Care’s London HQ yesterday with shareholders, advisors and our team all in one room, and with a good deal to report. Approaching completion of our FREEDOM clinical trial for Callavid®. A new second use case funded by Wellcome Leap, taking our drug delivery platform into …
Visiting the Ragon Institute
An inspiring visit to the Ragon Institute of Mass General Brigham, MIT, and Harvard catching up with Professor Doug Kwon and Meilin Zhu. Doug’s lab is at the front of the vaginal microbiome field: strain-level work on Lactobacillus, and more recently a Cell Host & Microbe paper on which host and microbial factors determine whether …
Dr Lara Zibners joins the UNC Center for the Business of Health Leadership Board
Our Dr Lara Zibners joins the UNC Center for the Business of Health Leadership Board. As noted by the Center: Lara is a board-certified pediatrician and pediatric emergency medicine specialist, she brings more than two decades of experience spanning clinical practice, medical education, and media, is an award-winning author, and proud alumus of UNC Kenan-Flagler …
CLCC publishes Menopause Education white paper
Our co-founder Dr Lara Zibners and Dr Adam Brown of ABIG Health have published a white paper on why menopause education belongs in core medical school curriculum, not at the margins of it. 58% of medical textbooks worldwide never mention menopause. Only 31.3% of OBGYN residency programs have a menopause curriculum. Please have a read …
Merck Healthcare / M Ventures’ W Accelerate Innovation programme
It really matters who is in the room you’re in. Two years ago Lara and I pitched at the inaugural Merck Healthcare / M Ventures W Accelerate Innovation programme run by W Group The event was fantastic. The seniority of the people in that room were impressive, and the conversations that started there became the …
University of Oxford SASHI 2026
Day Two of the Oxford Summer Academy for the Social Science of Health Innovation (SASHI)– The Women’s Health Revolution: Women’s and Reproductive Health Equity –held at St Hilda’s College, University of Oxford 🏛️ Great to return to Oxford for a fireside chat with Dr Emma Thornton. I talked about exciting progress on our progesterone-Callavid® clinical …
Chair of the WHH summit in Washington D.C.
Super excited to chair the Women’s Health Horizons DC summit on October 7 and be a panelist on “Medical Education as Health Policy: If We Don’t Teach It, We Don’t Treat It.” Everything policy and women’s health. It’s a real milestone in my life. The realization that everyone would prefer it if what I have …
Callavid feature in Technology Networks
We’re delighted to be featured by Technology Networks in this interview with our co-founders, Dr Lara Zibners and Thang Vo-Ta, about our Callavid® intravaginal drug delivery platform. Our first focus is progesterone delivery for threatened miscarriage and IVF– areas where the clinical need is significant, but where the patient experience has too often been overlooked. …
World Clinical Trials Day
It was recently World Clinical Trials Day, and our co-founder Lara took part in a special event hosted by SökerData and Covington & Burling LLP: 🔬 “Innovation in Action: Successful Women’s Clinical Trial Case Studies” 🧪 Lara shared the context, design and exciting early progress of our ongoing FREEDOM clinical trial evaluating Callavid® for threatened …
Returning to Barclays HQ for Demo Day
About 18 months after taking part in the inaugural Barclays Demo Day, it was great to return to Barclays’ Canary Wharf HQ to present Calla Lily Clinical Care again. Last time, we were pitching our ambitious plans to transform drug delivery for women. This time, those plans are bolder than ever– but now backed by …